Stocks
Petros Pharmaceuticals, Inc.PTPI
PNKHealthcarePharmaceuticals$0.00
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing prescription treatments for men's health, with its lead product addressing erectile dysfunction. The company is working to expand its pipeline and pursue FDA approvals for additional indications, making it a small-cap stock watched for regulatory catalysts and niche market positioning.
52W Range: $0.00-$0.02
Congressional Interest in Petros Pharmaceuticals, Inc. (PTPI)
No congressional trades have been disclosed for Petros Pharmaceuticals, Inc. (PTPI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PTPI?
No congressional trades found for this stock.